Amorphical Ltd.

21 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Oct 2028

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Dec 25, 2026
The maintenance fee for Stable Amorphous Calcium Carbonate Comprising Synthetic Phosphorylated Peptides (US 10,328,100) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

2 of the patents on this record were granted since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,328,100	Stable Amorphous Calcium Carbonate Comprising Synthetic Phosphorylated Peptides In force Term ends Oct 22, 2028 · Medium confidence	In force	Term ends Oct 22, 2028	Medium confidence
US 8,802,160	Stable Amorphous Calcium Carbonate Comprising Phosphorylated Amino Acids In force Ends no later than Apr 8, 2030 · Medium confidence	In force	Ends no later than Apr 8, 2030	Medium confidence
US 10,688,124	Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders In force Term ends Dec 13, 2032 · From the USPTO record	In force	Term ends Dec 13, 2032	From the USPTO record
US 10,064,890	Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders In force Term ends Mar 18, 2033 · From the USPTO record	In force	Term ends Mar 18, 2033	From the USPTO record
US 10,125,262	Method for producing stabilized amorphous calcium carbonate In force Term ends Aug 18, 2033 · From the USPTO record	In force	Term ends Aug 18, 2033	From the USPTO record
US 9,550,878	Method for producing stabilized amorphous calcium carbonate In force Term ends Sep 2, 2033 · From the USPTO record	In force	Term ends Sep 2, 2033	From the USPTO record
US 11,602,542	Non-Aqueous Liquid and Semi-Solid Formulations of Amorphous Calcium Carbonate In force Term ends Jul 30, 2035 · High confidence	In force	Term ends Jul 30, 2035	High confidence
US 12,714,726	Encapsulated Amorphous Calcium Carbonate Compositions In force Ends no later than Oct 8, 2035 · Medium confidence	In force	Ends no later than Oct 8, 2035	Medium confidence
US 10,758,565	Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration In force Term ends Jun 2, 2036 · From the USPTO record	In force	Term ends Jun 2, 2036	From the USPTO record
US 11,033,576	Compositions of Amorphous Calcium Carbonate for Inhalation, Sublingual or Buccal Administration In force Term ends Jun 2, 2036 · Medium confidence	In force	Term ends Jun 2, 2036	Medium confidence

10 of 21 patents shown.

Pro members see all 21.

Pro members: see all 21 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 2 abandoned · 2 no status recorded

List them